alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

Rosetta J. Wright,

Plaintiff,

v.

Bard Peripheral Vascular, Inc. and C. R. 

Bard, Inc., et al.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-03530-PHX-DGC

APPEARANCE OF COUNSEL

To: The clerk of court and all parties of record

I am admitted or otherwise authorized to practice in this court, and I appear in this case as counsel for:

Defendants C. R. Bard, Inc. and Bard Peripheral Vascular, Inc.

Date: November 27, 2017 /s/ Richard B. North, Jr.

Attorney's signature

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed name and bar number

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6000

Telephone number

(404 322-6050

FAX number

Case 2:15-md-02641-DGC Document 9194 Filed 12/06/17 Page 1 of 1
UAG ORGANIZATION

(as of March 20, 2024)

Nancy Colleton (Chair)

Dave Kaufman

Patrick Lin

Robbie Schingler

Sian Proctor

Jeremy Williams

Vacant (DFO)

Eric Fanning (Chair)

Bridget Chatman

Dawne Hickton

Dave Kaufman

Ron Lopez

Roosevelt 'Ted' Mercer

R.J. Balanga (DFO)

Lance Bush (Chair)

Charlie Bolden

Tory Bruno

Theodore 'Ted' Colbert

Gwynne Shotwell

James Taiclet

Kathy Warden

Ben Ashman (DFO)

Dan Hastings (Chair)

Rajeev Badyal

Bridget Chatman

Nancy Colleton

Marla Perez-Davis

Robbie Schingler

Jeremy Williams

Cody Kelly (DFO)

Mandy Vaughn (Chair)

Lance Bush

Bridget Chatman

Marla Perez-Davis

Sian Proctor

Katrina Williams

Barbara Adde (DFO)

Exploration and 

Discovery

Economic Development 

and Industrial Base

Climate and Societal 

Benefits

Data and Emerging 

Technology

STEM, Education, and 

Diversity & Inclusion

National Security*

(*) Security Clearance Holder

Lester Lyles (Chair) *

Roosevelt 'Ted' Mercer *

Charlie Bolden *

Tory Bruno *

Theodore 'Ted' Colbert *

Eric Fanning *

Dave Kaufman *

Dan Hastings *

Dawne Hickton *

Patrick Lin 

Ron Lopez *

Robbie Schingler *

Gwynne Shotwell *

James Taiclet *

Mandy Vaughn *

Kathy Warden *

Barbara Adde (DFO) *

`

UAG Executive Committee

Lester Lyles (UAG Chair)

Lance Bush

Nancy Colleton

Eric Fanning

Dan Hastings

Mandy Vaughn

James. J. Miller (UAG Exec. Secretary & DFO)

Barbara Adde (Deputy Exec. Secretary)
National Aeronautics and

Space Administration

Mary W. Jackson Building NASA Headquarters

Washington, DC 20546-0001

 

July 12, 2023

Reply to Attn of: General Law Practice Group

TO: Adam Greenstone

FROM: Ethics Attorney Advisor

SUBJECT: Determination Regarding Attendance by NASA Employees at the events in 

conjunction with the 2023 ECI Fellows Meeting on July 12–14, 2023

The Ethics and Compliance Initiative (ECI) will hold the 2023 Fellows Meeting on July 

12-14, 2023, at the Grand Hyatt Washington, 1000 H. St. NW, Washington, DC. from 4:00 

p.m. to 8:30 p.m. on July 12, from 8:00 am to 7:30 pm on July 13, and from 7:30 a.m. to 11 

a.m. on July 14. The Meeting is entitled “Catalyzing Ethical Leadership and Good 

Governance” It is a substantive conference focused on ethics and compliance leadership. 

Attendance will include a reception and dinner on July 12th, breakfast, lunch, and dinner on

July 13th, and breakfast on July 14th. ECI is in control of the planning, organizing, and 

issuing invitations for this event. ECI is comprised of two non-profits: the Ethics and 

Research Center (a 501(c)(3) non-profit organization) and the Ethics and Compliance 

Association (a 501(c)(6) non-profit organization).

Approximately 70 people are expected to attend the event. Attendees will have a diversity 

of views or interests and will include members of Congress, Executive Office of the 

President staff, trade association representatives, personnel from other federal agencies, 

members of the legislative branch, and representatives from media and industry. The 

complimentary cost of the event, including all food and beverages, is valued at $50 per 

person. Attendance at this event will allow NASA attendees to exchange information with 

other attendees regarding ethics and other NASA programs. I find that the event meets the 

requirements of a “widely attended gathering” as defined in 5 C.F.R. § 2635.204(g)(2). 

I further determine that there is an Agency interest in having NASA personnel attend the 

event because it will provide an opportunity for the invited persons to exchange ideas and 

views pertaining to NASA’s policies, programs and operations. Therefore, you may accept 

an invitation for free attendance at the event, based on the understanding that you do not 

have a significant role in a matter affecting the interests of the sponsor. In those 

circumstances, I find that the Agency’s interest in attendance outweighs any concern that 

you may be, or may appear to be, improperly influenced in the performance of your duties.

You are reminded to exercise any COVID-19 precautions appropriate to your individual 

situation.

Kathleen (Katie) Spear
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 2596 Introduced in Senate (IS)]

108th CONGRESS
  2d Session
                                S. 2596

To name the Department of Veterans Affairs outpatient clinic located in 
 Peoria, Illinois, as the ``Bob Michel Department of Veterans Affairs 
                          Outpatient Clinic''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 24, 2004

 Mr. Durbin (for himself and Mr. Fitzgerald) introduced the following 
 bill; which was read twice and referred to the Committee on Veterans' 
                                Affairs

_______________________________________________________________________

                                 A BILL

 
To name the Department of Veterans Affairs outpatient clinic located in 
 Peoria, Illinois, as the ``Bob Michel Department of Veterans Affairs 
                          Outpatient Clinic''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. NAME OF DEPARTMENT OF VETERANS AFFAIRS OUTPATIENT CLINIC, 
              PEORIA, ILLINOIS.

    The Department of Veterans Affairs outpatient clinic located in 
Peoria, Illinois, shall after the date of the enactment of this Act be 
known and designated as the ``Bob Michel Department of Veterans Affairs 
Outpatient Clinic''. Any reference to such outpatient clinic in any 
law, regulation, map, document, record, or other paper of the United 
States shall be considered to be a reference to the Bob Michel 
Department of Veterans Affairs Outpatient Clinic.
                                 <all>
```
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

 FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

SHAWN DERESE BRYANT,

Appellant,

v. Case No. 5D15-2347

STATE OF FLORIDA,

Appellee.

________________________________/

Opinion filed August 19, 2016

Appeal from the Circuit Court 

for St. Johns County,

J. Michael Traynor, Judge.

James S. Purdy, Public Defender, 

and Susan A. Fagan, Assistant Public 

Defender, Daytona Beach, for Appellant.

Pamela Jo Bondi, Attorney General, 

Tallahassee, Andrea K. Totten, Assistant 

Attorney General, Daytona Beach, for 

Appellee.

PER CURIAM

We affirm without prejudice to Appellant's right to file a timely, facially sufficient 

motion under Florida Rule of Criminal Procedure 3.850. 

AFFIRMED.

PALMER, WALLIS and EDWARDS, JJ., concur.
Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by
Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CV Therapeutics, Inc. (the Company) hereby certifies, to such officers knowledge, that:

(i) the accompanying Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2006, (the Report)
fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                         |  |  |  |                                    |  |                                                     |  | 
|------------------------ |  |  |  | ---------------------------------- |  | --------------------------------------------------- |  | 
|Dated: February 27, 2007 |  |  |  | /s/    LOUIS G. LANGE, M.D.,
PH.D.
|                         |  |  |  |                                    |  | Louis G. Lange, M.D., Ph.D. Chief
Executive Officer
AMENDMENT
      NO. 7


NON-COMPETITION
      AGREEMENT




AMENDMENT
      NO. 7, dated as of June 22, 2006, among THE STUDENT LOAN CORPORATION, a Delaware
      corporation (the “Company”), CITIBANK, N.A., a national banking association
      (“Citibank”), CITIGROUP INC., a Delaware corporation and the ultimate parent of
      Citibank (“Citigroup” and, together with Citibank, the “Parents”).





WHEREAS,
      the Company, Citibank (successor by merger to Citibank (New York State)), and
      Citicorp, a Delaware corporation, have heretofore entered into a Non-Competition
      Agreement, dated as of December 22, 1992, the term of which was extended
      pursuant to a letter agreement dated November 1, 1999, the term of which was
      further extended pursuant to Amendment No. 1 dated as of June 22, 2000,
      Amendment No. 2 dated as of June 22, 2001, Amendment No. 3 dated as of May
      5,
      2002, Amendment No. 4 dated as of June 22, 2003, Amendment No. 5 dated as of
      June 22, 2004 and Amendment No. 6 dated as of June 22, 2005, and Citigroup
      Inc.
      was substituted as a party in lieu of Citicorp (the Non-Competition Agreement,
      as so extended and amended, being referred to herein as the “Agreement”);
      and





WHEREAS,
      the parties to the Agreement wish to extend the term of the
      Agreement.





NOW,
      THEREFORE, for and in consideration of the premises and of other good and
      valuable consideration, the receipt and sufficiency of which are hereby
      acknowledged, the Company, Citibank and Citigroup hereby consent and agree
      as
      follows:





SECTION
      1. Unless otherwise defined in this Amendment No. 7, all defined terms used
      in
      this Amendment No. 6 shall have the meanings ascribed to such terms in the
      Agreement.





SECTION
      2. The term of the Agreement (originally scheduled to expire on December 22,
      1999, and previously extended to June 22, 2006) shall be extended for an
      additional twelve (12) months to June 22, 2007.





SECTION
      3. This Amendment No. 7 may be executed in two or more counterparts, each of
      which shall be an original, but all of which together shall constitute one
      and
      the same instrument.





SECTION
      4. From and after the date of this Amendment No. 7, all references in the
      Agreement to this “Agreement” shall refer to the Agreement as amended
      hereby.





IN
      WITNESS WHEREOF, the Company, Citibank and Citigroup have each caused this
      Amendment No. 7 to the Agreement to be duly executed by their respective
      officers as of the day and year first above written.








THE
      STUDENT LOAN CORPORATION




By
/s/
      Michael J. Reardon


Name:
      Michael J. Reardon


Title:
      Chief Executive Officer







CITIBANK,
      N.A.




By
/s/
      Paul D. Burner


Name:
      Paul D. Burner


Title: Chief
      Financial Officer







CITIGROUP
      INC.




By
/s/
      Steven J. Freiberg


Name:
      Steven J. Freiberg


Title:
      Co-Chairman, CEO Global Consumer Group
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Company's consolidated financial statements included in the Company's Quarterly
Report on Form 10-Q and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<MULTIPLIER> 1,000
           
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         333,317
<SECURITIES>                                         0
<RECEIVABLES>                                  141,963
<ALLOWANCES>                                    (2,816)
<INVENTORY>                                          0
<CURRENT-ASSETS>                               500,009
<PP&E>                                          25,183
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 879,020
<CURRENT-LIABILITIES>                          127,788
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            42
<OTHER-SE>                                     742,821
<TOTAL-LIABILITY-AND-EQUITY>                   742,863
<SALES>                                        190,077
<TOTAL-REVENUES>                               190,077
<CGS>                                          147,841
<TOTAL-COSTS>                                  147,841
<OTHER-EXPENSES>                                25,786
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 455
<INCOME-PRETAX>                                 21,560
<INCOME-TAX>                                     9,239
<INCOME-CONTINUING>                             12,321
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,321
<EPS-PRIMARY>                                      .31
<EPS-DILUTED>                                      .30
              

</TABLE>
ENDOGEN, INC.

                                                                    EXHIBIT 11.1


                   Computation of Net Income (Loss) Per Share
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                           Three Months Ended                    Six Months Ended
                                                               November 30,                         November 30,
                                                           1998            1997                 1998            1997
                                                     --------------   --------------      --------------   --------------
<S>                                                  <C>              <C>                 <C>              <C>         
BASIC
-----
Weighted average number of common
   shares outstanding                                   3,454,314        3,428,461           3,449,674        3,424,225
                                                     ==============   ==============      ==============   ==============

Net income (loss) applicable to common shares        $   (177,817)    $    171,715        $   (146,612)    $    265,893
                                                     ==============   ==============      ==============   ==============

Basic earnings (loss) per share                      $      (0.05)    $       0.05        $      (0.04)    $       0.08
                                                     ==============   ==============      ==============   ==============


DILUTED
-------
Weighted average number of common
  shares outstanding                                    3,454,314        3,428,461           3,449,674        3,424,225

Weighted average incremental shares from the
  assumed exercise of stock options and warrants               --          262,933                  --          213,761

                                                     --------------   --------------      --------------   --------------

                                                        3,454,314        3,691,394           3,449,674        3,637,986
                                                     ==============   ==============      ==============   ==============

Net income (loss) applicable to common shares
  and common equivalent shares                       $   (177,817)    $    171,715          $ (146,612)    $    265,893
                                                     ==============   ==============      ==============   ==============

Diluted earnings (loss) per share                    $      (0.05)    $       0.05          $    (0.04)    $       0.07
                                                     ==============   ==============      ==============   ==============
</TABLE>
#### STATE OF NEW JERSEY v. LENNON HINSON.

April 10, 1984.

Petition for certification denied.
#### ANNE M. DERELANKO v. BOARD OF TRUSTEES, PUBLIC EMPLOYEES’ RETIREMENT SYSTEM.

September 26, 1989.

Petition for certification denied.
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A19D0387. GINA INDIA MEDINA v. LAMONT MARTINEZ.

On January 22, 2019, the trial court entered an order denying Gina Medina’s

petition for modification of custody and child support. On March 13, 2019, Medina

filed, in this Court: (i) a motion for an extension of time in which to apply for

discretionary review of the trial court’s January 22 order and (ii) an application for

discretionary review of the January 22 order. For the reasons that follow, we deny

Medina’s request for an extension of time as untimely and dismiss her application for

discretionary review for lack of jurisdiction.

The trial court’s January 22 order was directly appealable under OCGA§ 5-6-34

(a) (11). This Court ordinarily will grant an application for discretionary review of a

directly appealable order under OCGA § 5-6-35 (j). To fall within this general rule,

however, the application must be filed within 30 days of entry of the order or

judgment sought to be appealed. See OCGA § 5-6-35 (d), (j). The requirements of

OCGA § 5-6-35 are jurisdictional, and this Court cannot accept an application for

appeal not made in compliance therewith. See Boyle v. State, 190 Ga. App. 734, 734

(380 SE2d 57) (1989).

Under OCGA § 5-6-39 (a) (5), this Court may grant an extension of time for

filing an application for discretionary review. See Gable v. State, 290 Ga. 81, 84-85

(2) (a) (720 SE2d 170) (2011); accord Court of Appeals Rule 16 (c). The request for

an extension, however, “must be made before expiration of the period for filing as

originallyprescribed or as extended by a permissible previous order.” OCGA§ 5-6-39

(d);see also Court of Appeals Rule 31 (i); Gable, 290 Ga. at 84-85 (2) (a).

April 09, 2019
Medina’s request for an extension of time in which to file an application for

discretionary review and her application for discretionary review of the January 22

order both are untimely, having been filed 50 days after the order was entered.

1 See

OCGA§§ 5-6-35 (d);5-6-39 (d);Court of Appeals Rule 31 (i); Gable, 290 Ga. at 84-85

(2) (a). Consequently, Medina’s motion for an extension of time in which to file an

application for discretionary review is hereby DENIED. Medina’s application for

discretionary review is hereby DISMISSED for lack of jurisdiction. See Boyle, 190

Ga. App. at 734.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

1 Given the untimeliness of Medina’s request for an extension of time, we

express no opinion as to whether the request violates Court of Appeals Rule 40 (b).

See Court of Appeals Rules 16 (c), 31 (i).

04/09/2019
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

William D. Jones,

Plaintiff,

v.

Bard Peripheral Vascular, Inc. and C. R. 

Bard, Inc., et al.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-04424-PHX-DGC

APPEARANCE OF COUNSEL

To: The clerk of court and all parties of record

I am admitted or otherwise authorized to practice in this court, and I appear in this case as counsel for:

Defendants C. R. Bard, Inc. and Bard Peripheral Vascular, Inc.

Date: February 1, 2018 /s/ Richard B. North, Jr.

Attorney's signature

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed name and bar number

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6000

Telephone number

(404 322-6050

FAX number

Case 2:15-md-02641-DGC Document 9960 Filed 02/05/18 Page 1 of 1
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 15

- 00284

- CR

John Hernandez

v.

The State of Texas §

§

§

§

§ From the 16th District Court

o f Denton County (F

- 2014

- 1924

- A )

June 16, 2016

Opinion by Justice Sudderth

(nfp)



### JUDGMENT

This court has considered the record on appeal in this case and holds that

there was no error in the trial court’s judgment. It is ordered that the judgment of

the trial court is affirmed.

SECOND DISTRICT COURT OF APPEALS

B y

_ /s/ Bonnie Sudderth

_______________ Justice Bonnie Sudderth
#### STATE OF NEW JERSEY v. ANDREW CLARK.

May 2, 1989.

Petition for certification denied.